AlphaGenome Atlas: a high-resolution map of human DNA

Google DeepMind and Google Cloud have launched AlphaGenome Atlas, a comprehensive, high-resolution map of the human genome. This initiative addresses the significant knowledge gap in understanding the 98% of the genome that does not code for proteins. Utilizing the AlphaGenome AI model, the project has pre-calculated the regulatory impact of all 9 billion possible single-letter genetic changes, resulting in a massive 1-petabyte dataset. The Atlas provides an AlphaGenome Variant Impact (AVI) score, simplifying the prioritization of genetic variants for researchers. This tool is already accelerating discoveries in rare diseases and complex traits by enabling scientists to quickly identify and focus on potentially impactful genetic variations. AlphaGenome Atlas is accessible via a no-code website, democratizing genomic research for biologists and clinicians worldwide and underscoring Google's commitment to advancing scientific discovery.

AI Signal Decode

AlphaGenome Atlas represents a significant leap in genomic analysis by providing predictions for the impact of every possible single nucleotide variant across the entire human genome. By leveraging the AlphaGenome AI model, Google has generated a 1-petabyte database that maps the regulatory effects of approximately 9 billion genetic changes. This exhaustive dataset allows scientists to move beyond studying the well-understood protein-coding regions to explore the vast, less-understood non-coding DNA, which plays a crucial role in gene regulation and molecular processes.

The introduction of the AlphaGenome Variant Impact (AVI) score is a key innovation, offering a unified metric that synthesizes predictions for both coding and non-coding regions. This simplifies complex genomic data, enabling researchers to rapidly identify and prioritize variants that are most likely to be functionally significant. Early applications demonstrate its utility, such as at the Broad Institute where it aided in solving a rare disease case by highlighting a critical variant in the DNM1 gene, and in UK Biobank research where it increased the identification of non-coding genetic associations for complex traits like BMI.

The accessibility of AlphaGenome Atlas through an intuitive, no-code web portal is designed to democratize its use among a wider range of researchers, including clinical biologists and geneticists without extensive bioinformatics expertise. This strategic move aims to accelerate the pace of biological discovery globally by empowering more scientists with advanced genomic insights. Google's ongoing commitment to scientific advancement is evident in making such a powerful resource readily available, fostering collaboration and innovation in genomics.